# Allogene Therapeutics, Inc.: Form DEF 14A, filed Apr 26, 2022

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: DEF 14A
- Filed: 2022-04-26
- Accepted by EDGAR: Apr 26, 2022, 16:28 ET
- Period: 2022-06-15
- Accession: 0001737287-22-000026
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728722000026/allo-20220414xdef14axdefin.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728722000026/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728722000026/allo-20220414xdef14axdefin.htm

Filed Apr 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001737287-22-000026. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
